Western University researchers have discovered that a chemical found in marijuana may be an effective treatment for schizophrenia by reducing psychiatric symptoms without the side effects of traditional medication.
The study shows cannabidiol, or CBD, affects the brain in a way that makes it treatment option for schizophrenia.
Paradoxially, this research comes just months after the same lab found that adolescent exposure to THC – the other major compound found in marijuana – may lead to the onset of schizophrenia in adulthood.
“The remarkable thing we were able to show with CBD, which actually acts as an atagonist to THC, is that it can actually shut down and regulate the dopamine system, normalize the dopamine activity, which is what we would expect to have in any sort of treatment to be effective in treating schizophrenia related symptoms,” says Western researcher Steven Laviolette.
Laviolette and his team, led by postdoctoral researcher Justine Renaud, were able